ProShare Advisors’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-12,344
| Closed | -$62K | – | 2425 |
|
|
2021
Q1 | $62K | Buy |
12,344
+1,062
| +9% | +$5.33K | ﹤0.01% | 2213 |
|
|
2020
Q4 | $143K | Buy |
+11,282
| New | +$143K | ﹤0.01% | 1932 |
|
|
2019
Q2 | – | Sell |
-10,307
| Closed | -$124K | – | 1667 |
|
|
2019
Q1 | $124K | Buy |
10,307
+136
| +1% | +$1.64K | ﹤0.01% | 1549 |
|
|
2018
Q4 | $128K | Sell |
10,171
-1,982
| -16% | -$24.9K | ﹤0.01% | 1443 |
|
|
2018
Q3 | $180K | Sell |
12,153
-482
| -4% | -$7.14K | ﹤0.01% | 1615 |
|
|
2018
Q2 | $213K | Sell |
12,635
-185
| -1% | -$3.12K | ﹤0.01% | 1580 |
|
|
2018
Q1 | $294K | Sell |
12,820
-2,111
| -14% | -$48.4K | ﹤0.01% | 1330 |
|
|
2017
Q4 | $386K | Buy |
+14,931
| New | +$386K | ﹤0.01% | 1259 |
|
|
2016
Q4 | – | Sell |
-15,648
| Closed | -$158K | – | 1758 |
|
|
2016
Q3 | $158K | Sell |
15,648
-2,910
| -16% | -$29.4K | ﹤0.01% | 1378 |
|
|
2016
Q2 | $208K | Buy |
18,558
+326
| +2% | +$3.65K | ﹤0.01% | 1400 |
|
|
2016
Q1 | $249K | Sell |
18,232
-1,766
| -9% | -$24.1K | ﹤0.01% | 1300 |
|
|
2015
Q4 | $379K | Buy |
19,998
+1,809
| +10% | +$34.3K | ﹤0.01% | 1174 |
|
|
2015
Q3 | $341K | Sell |
18,189
-1,107
| -6% | -$20.8K | ﹤0.01% | 1096 |
|
|
2015
Q2 | $287K | Buy |
19,296
+4,643
| +32% | +$69.1K | ﹤0.01% | 1323 |
|
|
2015
Q1 | $222K | Buy |
14,653
+2,609
| +22% | +$39.5K | ﹤0.01% | 1664 |
|
|
2014
Q4 | $160K | Buy |
+12,044
| New | +$160K | ﹤0.01% | 1782 |
|